Cargando…

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease

Parkinson’s disease (PD) is one of the most common neurodegenerative movement disorders which is characterised neuropathologically by progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the presence of Lewy bodies (made predominately of α-synuclein) in the survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Isaac, Corrigan, Frances, Zhai, Guangxi, Zhou, Xin-Fu, Bobrovskaya, Larisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474547/ https://www.ncbi.nlm.nih.gov/pubmed/34589845 http://dx.doi.org/10.1016/j.bbih.2020.100060

Ejemplares similares

Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease in C57BL/6 Mice
por: Deng, Isaac, et al.
Publicado: (2021)

Lipopolysaccharide mouse models for Parkinson’s disease research: a critical appraisal
por: Deng, Isaac, et al.
Publicado: (2022)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal Studies
por: Senthilkumaran, Manjula, et al.
Publicado: (2016)

Bioactive constituents from cinnamon, hemp seed and polygonum cuspidatum protect against H(2)O(2) but not rotenone toxicity in a cellular model of Parkinson's disease
por: Maiolo, Suzanne A., et al.
Publicado: (2018)

Cell Therapy for Neurological Disorders: The Perspective of Promising Cells
por: Liu, Donghui, et al.
Publicado: (2021)

An Imbalance in the Pro/mature BDNF Ratio Occurs in Multiple Brain Regions During Normal Ageing in Wild-Type Mice
por: Cade, Shaun, et al.
Publicado: (2023)

The Effects of Stress and Diet on the “Brain–Gut” and “Gut–Brain” Pathways in Animal Models of Stress and Depression
por: Herselman, Mauritz F., et al.
Publicado: (2022)

Recent Progress of Imaging Agents for Parkinson's Disease
por: Wu, Xiaoai, et al.
Publicado: (2014)

Progress in LRRK2-Associated Parkinson’s Disease Animal Models
por: Seegobin, Steven P., et al.
Publicado: (2020)

Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease
por: Wang, Xin-Hong, et al.
Publicado: (2017)

Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease
por: Guo, Yanmin, et al.
Publicado: (2015)

Glucocerebrosidase and its relevance to Parkinson disease
por: Do, Jenny, et al.
Publicado: (2019)

Recent Developments in Parkinson's Disease
por: Tsai, Diane C.
Publicado: (1986)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Urine-derived cells for human cell therapy
por: Pavathuparambil Abdul Manaph, Nimshitha, et al.
Publicado: (2018)

Correction to: Urine-derived cells for human cell therapy
por: Manaph, Nimshitha Pavathuparambil Abdul, et al.
Publicado: (2018)

Sex-Dependent Effects of Chronic Restraint Stress on Mood-Related Behaviours and Neurochemistry in Mice
por: Herselman, Mauritz Frederick, et al.
Publicado: (2023)

The Effects of Chronic Unpredictable Mild Stress and Semi-Pure Diets on the Brain, Gut and Adrenal Medulla in C57BL6 Mice
por: Herselman, Mauritz Frederick, et al.
Publicado: (2023)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Autoimmunity, dendritic cells and relevance for Parkinson’s disease
por: Koutsilieri, E., et al.
Publicado: (2012)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
por: Rakowski, Michał, et al.
Publicado: (2022)

The Effects of Walnuts and Academic Stress on Mental Health, General Well-Being and the Gut Microbiota in a Sample of University Students: A Randomised Clinical Trial
por: Herselman, Mauritz F., et al.
Publicado: (2022)

Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease
por: Pal, Gian D., et al.
Publicado: (2015)

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
por: Hasegawa, Satoru, et al.
Publicado: (2015)

Recent developments in biomarkers in Parkinson disease
por: Schapira, Anthony H.V.
Publicado: (2013)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Recent advances in treating Parkinson’s disease
por: Oertel, Wolfgang H.
Publicado: (2017)

Recent developments in the treatment of Parkinson's Disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules
por: Liu, Donghui, et al.
Publicado: (2022)

Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
por: Lu, Chenyu, et al.
Publicado: (2022)

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
por: Politis, Marios, et al.
Publicado: (2011)

Parkinson disease with constipation: clinical features and relevant factors
por: Yu, Qiu-Jin, et al.
Publicado: (2018)

The Role of Endophilin A1 in Lipopolysaccharide-Induced Parkinson’s Disease Model Mice
por: Han, Junhui, et al.
Publicado: (2023)

Recent Progress on Tick-Borne Animal Diseases of Veterinary and Public Health Significance in China
por: Jia, Weijuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_70p2bio9o0su82rcuj0ts8moq1